Table 4.

Treatment targets that were met 5 years after study inclusion in Austrian patients with stable CAD (N, [%])^h

Variable	Patients with stable CAD (N = 305)
Normalized blood pressurea	134/229 (58.5)
Lowered LDL cholesterol 1b	138/196 (70.4)
Lowered LDL cholesterol 2c	48/196 (24.5)
Lowered HbA1c 1d	33/77 (42.9)
Lowered HbA1c 2e	20/77 (26.0)
HR ≤ 60 bpmf	3/7 (42.9)
Smoking cessationg	16/38 (42.1)

bpm beats per minute, HbA1c glycated hemoglobin, HR heart rate, LDL low-density lipoprotein, N number of patients

^ain treated hypertensive patients, defined as systolic blood pressure <140 mm Hg, diastolic blood pressure <90 mm Hg

^bin patients with dyslipidaemia at baseline, defined as LDL cholesterol plasma level <1.0 g/l or 2.6 mmol/l

^cin patients with dyslipidaemia at baseline, defined as LDL cholesterol plasma level <0.7 g/l or 1.8 mmol/l

^din diabetic patients, defined as HbAc1 level <7.0%

^ein diabetic patients, defined as HbAc1 level <6.5%

^fin patients with anginal symptoms

^gfor current smokers at baseline

^hpercentages are of the data available